{"version":"1.0","provider_name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","provider_url":"https:\/\/brakkeconsulting.com\/ja","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"e0fVGFOG5L\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/14182\/\">2003\u5e742\u670814\u65e5\u306e\u52d5\u7269\u5065\u5eb7\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/ja\/14182\/embed\/#?secret=e0fVGFOG5L\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for February 14, 2003&#8221; &#8212; Brakke Consulting Website\" data-secret=\"e0fVGFOG5L\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"****************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 14, 2003 Copyright &copy; Brakke Consulting, Inc. ****************************************************************** COMPANY EARNINGS RELEASES &gt;&nbsp; Virbac SA announced provisional turnover for the year 2002 was 367 million euros ($388 million), an increase of 5% over 2001.&nbsp; The companion animal business grew 10% reinforced by sales of new products.&nbsp; The animal feed business recorded a 3% decrease following Virbac&rsquo;s decision to reduce this activity in Brazil.&nbsp; (Animal Pharm) &gt;&nbsp; Dainippon reported net sales of 12.4 billion yen ($103 million) for its animal science division for the first half of the fiscal year.&nbsp; Sales through September 30, 2002 showed a 6.5% increase over the comparable period in the prior year. (Animal Pharm) &gt;&nbsp; Heska reported financial results for the year ended December 31, 2002.&nbsp; Total companion animal health product sales for the year were up 10% to $35.9 million, while total food animal health product sales for the year were up 4% to $14.2 million.&nbsp; (company press release) &gt;&nbsp; Evialis reported turnover for the first nine months of 2002 were 552 million euros ($589 million) a decrease of 5.7%.&nbsp; Third quarter turnover fell to 168 million euros ($179 million) compared with 180 million euros in the prior year third quarter. The downturn in demand for the company&rsquo;s main product range was partially offset by theView Full Post;"}